Global Phytopathological Disease Diagnostics Market to Reach USD 163.4 Million by 2034, Driven by Growing Focus on Food Security and Sustainable Agriculture

The global phytopathological disease diagnostics market is set for significant growth over the next decade, with market projections indicating a rise from USD 105.2 million in 2024 to an estimated USD 163.4 million by 2034. This represents a steady compound annual growth rate (CAGR) of 4.5%, driven by increasing global concerns over food security and the growing adoption of sustainable agricultural practices.

As the world grapples with challenges posed by climate change, crop diseases, and the need to boost food production, effective diagnostics for plant diseases have become critical in ensuring high crop yields and protecting food supplies. The use of advanced diagnostic tools is helping farmers and agricultural experts detect, monitor, and control plant pathogens more efficiently, minimizing the risk of large-scale crop losses.

The market’s projected growth reflects a broader trend of investment in agricultural technology, as nations and organizations worldwide prioritize safeguarding crops against an ever-expanding range of diseases. Innovations in molecular diagnostics, biotechnology, and precision farming are anticipated to drive this market forward, enhancing the ability to diagnose phytopathological diseases early and accurately.

Key Takeaways from the Market Study:

  • Serological Tests: This segment emerges as the dominant market player, capturing a significant share of 58.1% in 2024, driven by its effectiveness in detecting antibodies in response to specific pathogens.
  • Diagnostic Kits: Holding a substantial market share of 43.4% in 2024, diagnostic kits continue to dominate the product category, reflecting their critical role in the industry.
  • Regional Insights: The United States maintains its leadership position in the market, with a consistent CAGR of 3.9% projected through 2034. Meanwhile, the United Kingdom anticipates a more measured growth rate with a projected CAGR of 2.2% by 2034. India’s market, however, is set to expand significantly with a remarkable CAGR of 6% through 2034.

Competitive Landscape and Industry Developments:

The phytopathological disease diagnostics market is undergoing rapid evolution, driven by both technological advancements and increasing global concerns about food security. Established diagnostic methods such as PCR and ELISA continue to dominate, but emerging technologies like AI-driven image analysis and portable DNA sequencers are reshaping the landscape, offering both opportunities and challenges for industry players.

The competition in this industry is intense, with traditional diagnostic companies vying against research institutions and agricultural biotechnology firms. As the demand for precision agriculture and sustainable farming practices grows, companies must differentiate themselves by providing comprehensive disease management solutions that integrate diagnostics with actionable insights and agronomic recommendations.

Recent Industry Developments:

  • Michigan State University’s Plant & Pest Diagnostics and MDARD’s Plant Pathology Laboratory are advancing agricultural standards with cutting-edge diagnostic solutions.
  • Agdia Inc. has revolutionized plant virus identification with the introduction of the Thrips Spot Viruses ImmunoComb, a portable and efficient tool for growers worldwide.
  • Abingdon Health plc has partnered with Morrama Ltd to form Eco-Flo Innovations Ltd, pioneering sustainable lateral flow test housings for eco-conscious diagnostics.
  • Planet Labs PBC has expanded its data analytics capabilities with the acquisition of Sinergise, heralding a new era of precision in plant disease identification and agricultural surveillance.

High Demand for Phytopathological Disease Diagnostics: Uncover the Trends and Insights with Our Detailed Report!

Leading Companies in the Industry:

Key players in the phytopathological disease diagnostics market include ThermoFisher Scientific, Clear Detections B.V, Merck KGaA, Agdia, Inc., and Qualiplante SAS. These companies are at the forefront of innovation, driving the market forward with their advanced diagnostic solutions.

Key Segments of Market Report:

By Product Type:

Product segments in the industry include kits such as ELISA kits, DNA-based diagnostics kits, and protein-based diagnostics kits. Additionally, there are lateral flow devices, DNA/RNA probes, and accessories and other consumables. software and cloud databases are also part of this category.

By Test Type:

Test segments encompass molecular tests, which consist of PCR-based assays, PCR & RT-PCR, and multiplex PCR. isothermal amplification assays, microarray assays, NASBA, and LAMP assays are also included. serological tests, like ELSIA, TBIA, and QCMI, along with tests using electronic technology, complete this category.

By Sample Type:

Sample types for testing include seeds, grains, plants, trees, and fruits.

By End User:

End users of these products and tests can be agricultural laboratories, academic and research institutes, food processing laboratories, contract research organizations, and others who utilize these tools and technologies for various purposes.

By Region:

The industry is segmented by regions which are North America, Latin America, Europe, East Asia, South Asia and Pacific, and the Middle East and Africa.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Matched content

Editor’s pick

Express Press Release Distribution